Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle
Open Access
- 1 May 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (5) , 832-835
- https://doi.org/10.1038/mt.2008.52
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Novel Mutation in Splicing Donor of Dystrophin Gene First Exon in a Patient With Dilated Cardiomyopathy but No Clinical Signs of Skeletal MyopathyJournal of Child Neurology, 2007
- Mesoangioblast stem cells ameliorate muscle function in dystrophic dogsNature, 2006
- A highly functional mini-dystrophin / GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophyHuman Molecular Genetics, 2006
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathologyNature Medicine, 2006
- Dystrophic heart failure blocked by membrane sealant poloxamerNature, 2005
- Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle DegenerationScience, 2005
- Functional improvement of dystrophic muscle by myostatin blockadeNature, 2002
- Dystrophin‐deficient cardiomyocytes are abnormally vulnerable to mechanical stress‐induced contractile failure and injuryThe FASEB Journal, 2001
- A Point Mutation in the 5' Splice Site of the Dystrophin Gene First Intron Responsible for X-Linked Dilated CardiomyopathyHuman Molecular Genetics, 1996
- X-Linked Dilated CardiomyopathyNew England Journal of Medicine, 1987